Cardiac Rhythm News

Aug 1, 2022 | Cardiac Rhythm News
AF after surgery is linked to an increased risk of heart failure hospitalisation

People who develop an arrhythmia after surgery have an increased risk of subsequently being admitted to hospital with heart failure, according to a study of over three million patients published in the European Heart Journal.

May 16, 2022 | Cardiac Rhythm News
HRS 2022: AI-based app used to detect left-ventricular dysfunction

Use of an artificial intelligence (AI)-based app using electrocardiogram (ECG) signals recorded with an Apple Watch is able to identify left-ventricular dysfunction, research presented at the Heart Rhythm Society’s 2022 annual meeting (HRS 2022, 29 April–1 May, San Francisco, USA) has found.

Mar 2, 2022 | Cardiac Rhythm News
Researchers warn of safety risk to ICDs from mobile devices

Portable electronic devices containing magnets may inhibit pulse generators for implanted cardiac devices (ICDs) and pacemakers according to new research published in Circulation: Arrhythmia and Electrophysiology.

Jan 7, 2022 | Cardiac Rhythm News
NICE approves KardiaMobile for AF detection in patients with suspected paroxysmal AF

The National Institute for Health and Care Excellence (NICE) has issued Medical Technologies Guidance (MTG) recommending KardiaMobile (AliveCor) as an option for detecting atrial fibrillation (AF) in patients with suspected paroxysmal AF, who present with symptoms such as palpitations and are referred for ambulatory ECG monitoring by a clinician.

Sep 30, 2021 | Cardiac Rhythm News
Abbott’s Amplatzer Talisman gains FDA approval

Abbott has announced that the US Food and Drug Administration (FDA) has approved the company’s Amplatzer Talisman PFO Occlusion System to treat people with a patent foramen ovale (PFO)—a small opening between the upper chambers of the heart—who are at risk of recurrent ischaemic stroke.

Aug 2, 2021 | Cardiac Rhythm News
Tyrx envelope shown to be cost effective in European healthcare markets

Economic analyses from the WRAP-IT study, sponsored by Medtronic, demonstrate the Tyrx cardiac absorbable antibacterial envelope’s (Tyrx Envelope) cost effectiveness in European markets for patients at increased risk of infections.

Filter by Journal